WEBSITE BSE:544088 NSE : MEDIASSIST 18 May, 12:50
Market Cap ₹3446 Cr.
Stock P/E 40.9
P/B 7.3
Current Price ₹490.1
Book Value ₹ 67.5
Face Value 5
52W High ₹563
Dividend Yield 0.82%
52W Low ₹ 430.2
Medi Assist Healthcare Services Limited (MAHSL) is a health-tech and insurance-tech company that manages health benefits for employers, retail members, and public health schemes, primarily serving insurance companies. MAHSL was incorporated in 2000 and has grown to become one of the largest third party administrators in India, with a network of over 18,000 providers and 35 insurer partnerships. MAHSL's portfolio of services includes benefits administration, international private medical insurance, self-funded plans, medical value travel, and borderless network access. The company also provides digital solutions such as MediBuddy, a platform that enables online access to health benefits and wellness services. Medi Assist has a vision to deliver informed healthcare decisions to a billion lives connected by its technology, partnerships and human touch.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) | Dec 2022 | Mar 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|
| Net Sales | 125 | 136 | 166 | 167 |
| Other Income | 6 | 3 | 4 | 4 |
| Total Income | 132 | 139 | 170 | 171 |
| Total Expenditure | 95 | 105 | 132 | 130 |
| Operating Profit | 37 | 34 | 38 | 41 |
| Interest | 1 | 1 | 1 | 1 |
| Depreciation | 6 | 8 | 11 | 12 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 |
| Profit Before Tax | 30 | 25 | 26 | 28 |
| Provision for Tax | 9 | 8 | 4 | 3 |
| Profit After Tax | 21 | 17 | 21 | 26 |
| Adjustments | 0 | -1 | -1 | -1 |
| Profit After Adjustments | 22 | 16 | 21 | 25 |
| Adjusted Earnings Per Share | 3.1 | 2.3 | 3 | 3.6 |
| #(Fig in Cr.) | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
|---|---|---|---|---|---|---|---|
| Net Sales | 341 | 406 | 319 | 323 | 394 | 505 | 594 |
| Other Income | 11 | 4 | 12 | 25 | 28 | 22 | 17 |
| Total Income | 352 | 410 | 330 | 348 | 422 | 527 | 612 |
| Total Expenditure | 270 | 331 | 241 | 249 | 312 | 394 | 462 |
| Operating Profit | 82 | 80 | 90 | 98 | 109 | 133 | 150 |
| Interest | 4 | 4 | 4 | 6 | 3 | 3 | 4 |
| Depreciation | 19 | 25 | 26 | 32 | 28 | 27 | 37 |
| Exceptional Income / Expenses | 0 | -11 | 0 | 0 | 3 | 0 | 0 |
| Profit Before Tax | 59 | 39 | 59 | 61 | 81 | 104 | 109 |
| Provision for Tax | 19 | 13 | 21 | 23 | 17 | 28 | 24 |
| Profit After Tax | 40 | 26 | 38 | 38 | 63 | 75 | 85 |
| Adjustments | 0 | 0 | -8 | -11 | 1 | -1 | -3 |
| Profit After Adjustments | 40 | 26 | 31 | 27 | 64 | 74 | 84 |
| Adjusted Earnings Per Share | 6.2 | 3.9 | 4.6 | 3.9 | 9.3 | 10.8 | 12 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 28% | 17% | 8% | 0% |
| Operating Profit CAGR | 22% | 14% | 10% | 0% |
| PAT CAGR | 19% | 25% | 13% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | NA% | NA% | NA% | NA% |
| ROE Average | 22% | 19% | 18% | 18% |
| ROCE Average | 30% | 27% | 24% | 24% |
| #(Fig in Cr.) | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|---|---|
| Shareholder's Funds | 204 | 218 | 211 | 290 | 337 | 377 |
| Minority's Interest | 3 | 2 | 2 | 2 | 2 | 7 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 43 | 41 | 39 | 113 | 19 | 34 |
| Total Current Liabilities | 229 | 255 | 302 | 219 | 234 | 279 |
| Total Liabilities | 480 | 516 | 555 | 624 | 593 | 697 |
| Fixed Assets | 132 | 142 | 138 | 119 | 99 | 171 |
| Other Non-Current Assets | 81 | 91 | 110 | 133 | 69 | 83 |
| Total Current Assets | 267 | 283 | 308 | 370 | 425 | 442 |
| Total Assets | 480 | 516 | 555 | 624 | 593 | 697 |
| #(Fig in Cr.) | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 15 | 6 | 11 | -5 | 63 | 15 |
| Cash Flow from Operating Activities | 40 | 35 | 17 | 139 | 64 | 81 |
| Cash Flow from Investing Activities | -42 | -21 | -21 | -61 | -83 | -10 |
| Cash Flow from Financing Activities | -7 | -10 | -12 | -10 | -30 | -32 |
| Net Cash Inflow / Outflow | -9 | 4 | -16 | 69 | -49 | 39 |
| Closing Cash & Cash Equivalent | 6 | 10 | -5 | 63 | 15 | 54 |
| # | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 6.24 | 3.93 | 4.58 | 3.89 | 9.33 | 10.76 |
| CEPS(Rs) | 0 | 0 | 0 | 0 | 13.34 | 14.82 |
| DPS(Rs) | 0 | 0 | 0 | 2.5 | 1.89 | 1.89 |
| Book NAV/Share(Rs) | 30.46 | 31.85 | 30.87 | 41.56 | 47.81 | 53.08 |
| Core EBITDA Margin(%) | 20.82 | 18.55 | 24.37 | 22.76 | 20.66 | 22.03 |
| EBIT Margin(%) | 18.38 | 10.72 | 19.83 | 20.69 | 21.24 | 21.11 |
| Pre Tax Margin(%) | 17.34 | 9.67 | 18.66 | 18.91 | 20.49 | 20.52 |
| PAT Margin (%) | 11.85 | 6.45 | 11.98 | 11.78 | 16.12 | 14.91 |
| Cash Profit Margin (%) | 17.39 | 12.56 | 20.24 | 21.54 | 23.33 | 20.22 |
| ROA(%) | 8.43 | 5.26 | 7.12 | 6.44 | 10.43 | 11.68 |
| ROE(%) | 20.48 | 12.78 | 18.25 | 15.49 | 20.67 | 21.68 |
| ROCE(%) | 24.45 | 16.52 | 22.82 | 23.27 | 26.66 | 29.87 |
| Receivable days | 104.41 | 84.43 | 134 | 149.74 | 111.15 | 88.89 |
| Inventory Days | 0 | 0 | 0 | 0 | 0 | 0 |
| Payable days | 0 | 0 | 0 | 0 | 0 | 0 |
| PER(x) | 0 | 0 | 0 | 0 | 0 | 0 |
| Price/Book(x) | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 0.12 | 0.1 | 0.1 | -0.36 | -0.07 | -0.35 |
| EV/Core EBITDA(x) | 0.5 | 0.49 | 0.37 | -1.17 | -0.26 | -1.33 |
| Net Sales Growth(%) | 0 | 18.94 | -21.54 | 1.3 | 22.02 | 28.22 |
| EBIT Growth(%) | 0 | -30.63 | 45.16 | 5.67 | 25.27 | 27.45 |
| PAT Growth(%) | 0 | -35.24 | 45.69 | -0.39 | 66.99 | 18.66 |
| EPS Growth(%) | 0 | -37.04 | 16.59 | -14.97 | 139.47 | 15.32 |
| Debt/Equity(x) | 0.27 | 0.25 | 0.35 | 0 | 0 | 0 |
| Current Ratio(x) | 1.17 | 1.11 | 1.02 | 1.7 | 1.81 | 1.59 |
| Quick Ratio(x) | 1.17 | 1.11 | 1.02 | 1.7 | 1.81 | 1.59 |
| Interest Cover(x) | 17.69 | 10.17 | 16.93 | 11.66 | 28.35 | 35.66 |
| Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 0 | 0 |
| # | Mar 2024 |
|---|---|
| Promoter | 38.91 |
| FII | 9.67 |
| DII | 30.61 |
| Public | 20.81 |
| Others | 0 |
| Total | 100 |
| # | Mar 2024 |
|---|---|
| Promoter | 2.73 |
| FII | 0.68 |
| DII | 2.15 |
| Public | 1.46 |
| Others | 0 |
| Total | 7.02 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
You May Also Know About
